Association of ADIPOQ, LEP, and FTO gene polymorphisms with large for gestational age infants

Caroline Kroll1, Silmara S B S Mastroeni2,3, Paul J Veugelers2

  • 1Post-Graduation Program in Health and Environment, University of Joinville Region, Joinville, Santa Catarina, 89.219-710, Brazil.

Insights

The GG genotype of the LEP rs7799039 polymorphism increases the risk of large for gestational age (LGA) births in Brazilian infants. Further research is needed to understand the exact mechanisms involved in birth weight regulation.

Area of Science:

  • Genetics
  • Pediatrics
  • Reproductive Health

Background:

  • Birth weight is a critical indicator of neonatal health.
  • Genetic factors play a significant role in determining fetal growth and birth weight.
  • Polymorphisms in genes like ADIPOQ, LEP, and FTO are investigated for their association with birth weight variations.

Purpose of the Study:

  • To evaluate the impact of ADIPOQ rs2241766, LEP rs7799039, and FTO rs9939609 gene polymorphisms on the birth weight status of Brazilian newborns.
  • To identify specific genetic variants associated with large for gestational age (LGA) and small for gestational age (SGA) infants.

Main Methods:

  • A cross-sectional study was conducted in southern Brazil.
  • 105 LGA newborns and 105 small/adequate for gestational age newborns were included.
  • Genotyping was performed using PCR-RFLP, and logistic regression analyzed associations between polymorphisms and LGA status.

Main Results:

  • Infants with the GG genotype of LEP rs7799039 showed a 2.12-fold increased likelihood of being born LGA, a finding robust to adjustments.
  • A trend towards increased LGA risk was observed for ADIPOQ rs2241766 (TG/GG genotypes), though not statistically significant (p=0.082).
  • No significant association was found between the FTO rs9939609 polymorphism and newborn birth weight status.

Conclusions:

  • The GG genotype of the LEP polymorphism rs7799039 is identified as a risk factor for LGA infants in the studied Brazilian population.
  • The precise role and underlying mechanisms of this LEP genotype in controlling birth weight require further investigation.
  • Additional research is necessary to fully elucidate the genetic influences on birth weight and its clinical implications.
Abstract

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
63
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
351
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
19.1K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
96